Tag:
zibotentan
Latest Headlines
Latest Headlines
AZ's oral prostate cancer drug fails another Ph3 trial
AstraZeneca's late-stage cancer drug zibotentan has tumbled against yet another hurdle. Investigators for the company say they have decided to write off a Phase III prostate cancer study after
AZ's zibotentan flunks late-stage prostate cancer trial
AstraZeneca has suffered a setback in its oncology drug development strategy. The pharma giant reported that the closely watched prostate cancer therapy zibotentan failed a late-stage trial. At a
TheStreet tracks the top 10 clinical trials to watch
TheStreet's top biotech stock ace, Adam Feuerstein, has culled through a mountain of releases and reports to come up with the 10 most closely-watched trial announcements expected in the second half
